Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
biotech
Biopharma IPO outlook: A shift amid uncertainty?
While the biopharma IPO market has been sluggish, there may be a shift in the marketplace later this year, particularly for later-stage biopharma companies. … READ MORE >
5 things to know in life sciences: Week of March 24, 2025
Pharma companies collaborate on secure data sharing for AI. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of March 3, 2025
The importance of data governance in pharma’s AI integration. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Feb. 10, 2025
Large pharmaceutical companies are turning to AI more frequently, despite some challenges. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of November 18, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024–with early trials indicating improved patient outcomes and reduced disease activity, reports BioSpace. Researchers are optimistic about expanding … … READ MORE >
5 things to know in life sciences: Week of September 16, 2024
Recent transactions may indicate an opening in the biotech IPO market. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of August 12, 2024
Some big pharmaceutical companies are shifting from large acquisitions to smaller deals. This and more in this week’s recap. … READ MORE >
5 things to know in life sciences: Week of June 3, 2024
From biopharma research productivity to the impact of AI modeling, here’s the latest in life sciences. … READ MORE >
5 things to know in life sciences: Week of March 18, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >